Nabih Maslah

7PUBLICATIONS
28CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsHaematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2026
Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing.

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|May 22, 2024
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

Nabih Maslah, Salome Rety, Melina Bonnamy

|Jan 04, 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.

Panhong Gou, Duanya Liu, Saravanan Ganesan

|Dec 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Hélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur

|Jan 14, 2022
Single-cell analysis reveals selection of TP53-mutated clones after MDM2 inhibition.

Nabih Maslah, Emmanuelle Verger, Stéphane Giraudier

Pageof 2

Frequent Collaborators

6 joint publications

Bruno Cassinat

4 joint publications

Stéphane Giraudier

3 joint publications

Emmanuelle Verger

3 joint publications

William Vainchenker